MedPath

Goniotaire

Goniotaire

Approved
Approval ID

9ebedd36-523a-4f92-8fe9-33beaf7288f9

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 28, 2022

Manufacturers
FDA

Altaire Pharmaceuticals Inc.

DUNS: 786790378

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

HYPROMELLOSE 2906 (4000 MPA.S)

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59390-182
Product Classification
G
Generic Name
HYPROMELLOSE 2906 (4000 MPA.S)
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateOctober 31, 2022
FDA Product Classification

INGREDIENTS (8)

BORIC ACIDInactive
Code: R57ZHV85D4
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
SODIUM BORATEInactive
Code: 91MBZ8H3QO
Classification: IACT
HYPROMELLOSE 2906 (4000 MPA.S)Active
Quantity: 25 mg in 1 mL
Code: 5EYA69XGAT
Classification: ACTIB
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: CNTM
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: CNTM
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Goniotaire - FDA Drug Approval Details